ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 702106 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 702106; 2) Community: the network communities that were significantly associated with the response to NSC 702106; 3) Molecule: the relationships between components within communities and NSC 702106; 4) MDR: the compounds that were significantly associated with the NSC 702106.

NSC Compound Enrichment Correlation
NSC 752464 methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate 0.0407060322613561 -0.15522804
NSC 757113 METHOTREXATE(+/-) 0.0407060322613561 -0.23751179
NSC 88915 Null 0.0407060322613561 -0.076767501
NSC 95448 1H-1,2,4-Triazole, 3-(4-diazo-4H-imidazol-5-yl)- 0.0407060322613561 -0.082746441
NSC 112758 Rubomycin 0.0407060322613564 -0.0057702483
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.0407060322613564 -0.17539772
NSC 122656 Null 0.0407060322613564 -0.13033612
NSC 1390 Allopurinol 0.0407060322613564 -0.1500633
NSC 179074 Lead, bis[(2-cyanoethyl)cyclohexylcarbamodithioato-S,S']-, (T-4)- 0.0407060322613564 -0.17786279
NSC 282159 EN 589 0.0407060322613564 0.0037494259
Total:153  Current:134    [First] [Prev] [Next] [Last]